⁶⁸Ga-labelled somatostatin analogues

Clinical Evaluation	Somatostatin receptor expression
Type of Imaging	PET
Grade of Recommendation	A (strongly recommended)
Level of Evidence	well-established clinical and Nuclear Medicine recommendations
Effective Dose	17.0-23.0 µSv/MBq
Bibliographic Reference	Ambrosini V, Kunikowska J, Baudin E, Bodei L, Bouvier C, Capdevila J, Cremonesi M, de Herder WW, Dromain C, Falconi M, Fani M, Fanti S, Hicks RJ, Kaba... read more Ambrosini V, Kunikowska J, Baudin E, Bodei L, Bouvier C, Capdevila J, Cremonesi M, de Herder WW, Dromain C, Falconi M, Fani M, Fanti S, Hicks RJ, Kabasakal L, Kaltsas G, Lewington V, Minozzi S, Cinquini M, Öberg K, Oyen WJG, O'Toole D, Pavel M, Ruszniewski P, Scarpa A, Strosberg J, Sundin A, Taïeb D, Virgolini I, Wild D, Herrmann K, Yao J. Consensus on molecular imaging and theranostics in neuroendocrine neoplasms. Eur J Cancer. 2021; https://doi.org/10.1016/j.ejca.2021.01.008. read less
Guide to Nuclear Medicine	Read the corresponding chapter

Clinical Evaluation
Somatostatin receptor expression
Type of Imaging
PET
Grade of Recommendation
A (strongly recommended)
Level of Evidence
well-established clinical and Nuclear Medicine recommendations
Effective Dose
17.0-23.0 µSv/MBq
Bibliographic Reference
Ambrosini V, Kunikowska J, Baudin E, Bodei L, Bouvier C, Capdevila J, Cremonesi M, de Herder WW, Dromain C, Falconi M, Fani M, Fanti S, Hicks RJ, Kaba... read more Ambrosini V, Kunikowska J, Baudin E, Bodei L, Bouvier C, Capdevila J, Cremonesi M, de Herder WW, Dromain C, Falconi M, Fani M, Fanti S, Hicks RJ, Kabasakal L, Kaltsas G, Lewington V, Minozzi S, Cinquini M, Öberg K, Oyen WJG, O'Toole D, Pavel M, Ruszniewski P, Scarpa A, Strosberg J, Sundin A, Taïeb D, Virgolini I, Wild D, Herrmann K, Yao J. Consensus on molecular imaging and theranostics in neuroendocrine neoplasms. Eur J Cancer. 2021; https://doi.org/10.1016/j.ejca.2021.01.008. read less
Guide to Nuclear Medicine
Read the corresponding chapter

68Ga-labelled somatostatin analogues